KIHARA JAMES (Principal Accounting Officer) sold 4.4% of their position (1.33K shares) of ACADIA PHARMACEUTICALS INC on the open market
Open‑market sale worth $29.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/5/2026ACC: 0001816160-26-000007
Officer· Principal Accounting Officer
Since Jun 2020
-1.33K
Net shares
Net seller
$29.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.60K acquired · 3.93K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.60K
Price / share
—
Trade value
—
% of position
9.3%
5/1/2026
27.86K→30.46K
Common Stock
Direct
Shares
−1.33K
Price / share
$21.79
Trade value
$29.02K
% of position
4.4%
5/4/2026
30.46K→29.13K
Total
Net shares
+1.26K
Net value
-$29.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | M · Option Exercise | +2.60K | — | — | 9.3% | 27.86K | 30.46K |
| Common Stock Direct | 5/4/2026 | S · Sale | −1.33K | $21.79 | $29.02K | 4.4% | 30.46K | 29.13K |
| Total | +1.26K | -$29.02K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
2.60K shares
Shares
−2.60K
Strike price
Held after
2.60K
Exercisable
—
5/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock2.60K shares | 5/1/2026 | M · Option Exercise | −2.60K | — | 2.60K |